65505-18-2

Basic information

• Product Name: Thiazole, 5-ethenyl-2,4-dimethyl-
• Synonyms: Thiazole, 5-ethenyl-2,4-dimethyl-;FEMA No. 3145
• CAS NO: 65505-18-2
• Molecular Formula: C7H9NS
• Molecular Weight: 139.2181
• Product Categories: thiazole Flavor
• Mol File: 65505-18-2.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 202.5 °C at 760 mmHg
• Flash Point: 75.2 °C
• Appearance: /
• Density: 1.065 g/cm³
• Vapor Pressure: 0.414mmHg at 25°C
• Refractive Index: 1.577
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: Thiazole, 5-ethenyl-2,4-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Thiazole, 5-ethenyl-2,4-dimethyl-(65505-18-2)
• EPA Substance Registry System: Thiazole, 5-ethenyl-2,4-dimethyl-(65505-18-2)

Safety Data

• Hazardous Substances Data: 65505-18-2(Hazardous Substances Data)

Usage

Chemical Properties

2,4-Dimethyl-5-vinylthiazole has a nut-like flavor.

InChI:InChI=1/C7H9NS/c1-4-7-5(2)8-6(3)9-7/h4H,1H2,2-3H3

Relevant articles and documents

ORGANIC COMPOUNDS

Compounds of the formula (I) are inhibitors of protein tyrosine phosphatases (PTPases) and, thus, may be employed for the treatment of conditions mediated by PTPase activity. The compounds of the present invention may also be employed as inhibitors of other enzymes characterized with a phosphotyrosine binding region such as the SH2 domain. Accordingly, the compounds of formula (I) may be employed for prevention and/or treatment of insulin resistance associated with obesity, glucose intolerance, diabetes mellitus, hypertension and ischemic diseases of the large and small blood vessels, conditions that accompany type-2 diabetes, including hyperlipidemia, hypertriglyceridemia, atherosclerosis, vascular restenosis, irritable bowel syndrome, pancreatitis, adipose cell tumors and carcinomas such as liposarcoma, dyslipidemia, and other disorders where insulin resistance is indicated. In addition, the compounds of the present invention may be employed to treat and/or prevent cancer, osteoporosis, musculoskeletal, neurodegenerative and infectious diseases, and diseases involving inflammation and the immune system.